期刊文献+

慢性充血性心力衰竭患者促炎性细胞因子和心肌纤维化与心功能分级的相关性研究 被引量:5

Relationship of serum cytokine levels and myocardial fibrosis with cardiac funciton in patients with chronic heart failure
下载PDF
导出
摘要 目的分析慢性充血性心力衰竭(CHF)患者血清促炎性细胞因子(IL-6、TNF-α)和心肌纤维化指标(PCⅢ、HA、LN)及其与心功能分级的关系;探讨血管紧张素转换酶抑制剂'(ACEI)对CHF患者促炎性细胞因子和心肌纤维化水平调控作用。方法采用放射免疫平衡法和流式细胞仪的液相蛋白定量技术检测113例CHF患者及正常对照组38例血清促炎性细胞因子(IL-6、TNF-α)和心肌纤维化指标(PCⅢI、HA、LN)浓度,并作相关性分析。结果CHF组血清促炎性细胞因子(IL-6、TNF-α)和心肌纤维化指标(PCⅢ、LN、HA)显著高于正常对照组(P<0.05),且随着心功能的恶化而逐渐升高,血清促炎性细胞因子和心肌纤维化指标在不同心功能分级间(心功能Ⅱ、Ⅲ、Ⅳ级)比较均有显著性差异(P<0.05);血清促炎性细胞因子和心肌纤维化指标之间、心功能分级与血清促炎性细胞因子和心肌纤维化指标之间呈显著正相关;ACEI治疗组患者血清促炎性细胞因子和心肌纤维化指标水平较常规治疗组降低更明显,两组治疗后与治疗前比较、ACEI治疗组与常规治疗组比较差异均有统计学意义(P<0.05)。结论促炎性细胞因子的上调及心肌纤维化的程度与CHF的发生、发展、转归之间存在着一定的关联,与心衰严重程度密切相关;ACEI对CHF患者促炎性细胞因子和心肌纤维化水平具有调控作用。 Objective To investigate the relationship of serum eytokine levels (IL-6, TNF—α) and myocardial fibrosis ( PC Ⅲ, HA, LN) with cardiac function in patients with chronic heart failure (CHF). Methods Serum concentrations of cytokinelevels (IL-6, TNF—α) and serum myocardial fibrosis (PC Ⅲ, HA, LN) in 113 cases with CHF patients and 38 cases normalcontrol group were measured using radioimmunoassay balance method and CBABD-pharmingen Cytometric Bead Array (CBA), and for correlation analysis. Results CHF serum cytokines (IL-6, TNF—α) and myocardial fibrosis index (PC Ⅲ, LN, HA) was significantly higher than the normal control group (P 〈0. 05 ), and with the deterioration of cardiac function gradually ncreased, serum eytokines and myocardial fibrosis in different indicators of cardiac function between the ( cardiac functiongrade Ⅱ, Ⅲ ,Ⅳ level) compared were significantly different (P 〈0. 05 ); Serum cytokines and myocardial fibrosist indicators, cardiac function and serum eytokines and myocardial fibrosis indicators were significantly correlated; ACEI treatment group serum cytokine levels and myocardial fibrosis index lower than the conventional treatment group, mor - obviously, the two groups after treatment compared with before treatment, ACEI treatment group compared with the conventional treatment group were significantly different (P 〈0. 05). Conclusion Cytokineimbalance and the extent of myocardial fibrosis and the CHF occurrence, development, and the vesting have a certain relevance, and are related to the severity of heart failure; ACEI has a regulating role for cytokine levels and myocardial fibrosis in patients with CHF.
机构地区 解放军第
出处 《四川医学》 CAS 2009年第7期1035-1037,共3页 Sichuan Medical Journal
关键词 慢性充血性心力衰竭 促炎性细胞因子 心肌纤维化 贝那普利 相关性研究 chronic heart failure serum cytokine levels myocardial fibrosi benazepril related research
  • 相关文献

参考文献3

二级参考文献92

  • 1[10]Beggah AT,Escoubet B,Puttini S,et al.From the cover:reversible cardiac fibrosis and heart failure induced by conditional expression of an antisense mRNA of the mineralocorticoid receptor in cardiomyocytes.Proc Nat Acad Sci U S A 2002;99:7160-5.
  • 2[11]Sabbah HN,Sharov VG,Lesch M,et al.Progression of heart failure:a role for interstitial fibrosis.Mol Cell Biochem 1995;147:29-34.
  • 3[12]Zannad F,Alla F,Dousset B,et al.Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure:insights from the randomized aldactone evaluation study(RALES).Circulation 2000;102:2700-6.
  • 4[13]Zannad F,Dousset B,Alla F.Treatment of congestive heart failure:interfering the aldosterone-cardiac extracellular matrix relationship.Hypertension 2001;38:1227-32.
  • 5[14]Querejeta R,Lopez B,Gonzalez A,et al.Increased collagen type Ⅰ synthesis in patients with heart failure of hypertensive origin:relation to myocardial fibrosis.Circulation 2004;110:1263-8.
  • 6[1]Banff C,Cavalca V,Veglia F,et al.Neurohormonal activation is associated with increased levels of plasma matrix metalloproteinase-2 in human heart failure.Eur Heart J 2005;26:481-8.
  • 7[2]Reinhardt D,Sigusch HH,Hensse J,et al.Cardiac remodelling in end stage heart failure:upregulation of matrix metalloproteinase(MMP)irrespective of the underlying disease,and evidence for a direct inhibitory effect of ACE inhibitors on MMP.Heart2002;88:525-30.
  • 8[3]Yamazaki T,Lee JD,Shimizu H,et al.Circulating matrix metalloproteinase-2 is elevated in patients with congestive heart failure.Eur J Heart Fail 2004;6:41-5.
  • 9[4]Wilson EM,Gunasinghe HR,Coker ML,et al.Plasma matrix metalloproteinase and inhibitor profiles in patients with heart failure.J Card Fail 2002;8:390-8.
  • 10[5]Spinale FG,Coker ML,Heung LJ,et al.A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure.Circulation 2000;102:1944-9.

共引文献127

同被引文献86

引证文献5

二级引证文献107

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部